Europe Dog Vaccine Market Size & Outlook, 2025-2030

The dog vaccine market in Europe is expected to reach a projected revenue of US$ 816.9 million by 2030. A compound annual growth rate of 6.1% is expected of Europe dog vaccine market from 2025 to 2030.
Revenue, 2024 (US$M)
$574.6
Forecast, 2030 (US$M)
$816.9
CAGR, 2025 - 2030
6.1%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe dog vaccine market, 2018-2030 (US$M)

Europe dog vaccine market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe dog vaccine market highlights

  • The Europe dog vaccine market generated a revenue of USD 574.6 million in 2024.
  • The market is expected to grow at a CAGR of 6.1% from 2025 to 2030.
  • In terms of segment, modified/attenuated live was the largest revenue generating vaccine type in 2024.
  • Modified/Attenuated Live is the most lucrative vaccine type segment registering the fastest growth during the forecast period.

Europe data book summary

Market revenue in 2024USD 574.6 million
Market revenue in 2030USD 816.9 million
Growth rate6.1% (CAGR from 2025 to 2030)
Largest segmentModified/attenuated live
Fastest growing segmentModified/Attenuated Live
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationModified/Attenuated Live
Key market players worldwideZoetis Inc Class A, Boehringer Ingelheim GmbH, Merck & Co Inc, Elanco Animal Health Inc, Virbac SA, Bioveta, Hester Biosciences, Brilliant Bio Pharma, HESKA, Zendal

Other key industry trends

  • In terms of revenue, Europe region accounted for 28.9% of the global dog vaccine market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 605.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Dog Vaccine Market Companies

Name Profile # Employees HQ Website
Boehringer Ingelheim GmbH View profile - - -
Zendal View profile 501-1000 Pontevedra, Galicia, Spain, Europe https://www.zendal.com
Brilliant Bio Pharma View profile 251-500 Hyderabad, Andhra Pradesh, India, Asia https://www.brilliantbiopharma.com/index.html
Hester Biosciences View profile 251-500 San Diego, California, United States, North America http://www.hesterbiosciences.co.in
Bioveta View profile 101-250 Ivanovice Na Hané, Jihomoravsky kraj, Czech Republic, Europe https://www.bioveta.cz
HESKA View profile 501-1000 Loveland, Colorado, United States, North America http://heska.com
Elanco Animal Health Inc View profile 9800 2500 Innovation Way, Greenfield, IN, United States, 46140 https://www.elanco.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Virbac SA View profile 5400 2065m LID, 1 ere avenue, Carros, France, 06516 https://www.virbac.com
Zoetis Inc Class A View profile 14100 10 Sylvan Way, Parsippany, NJ, United States, 07054 https://www.zoetis.com

Europe dog vaccine market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dog vaccine market will help companies and investors design strategic landscapes.


Modified/attenuated live was the largest segment with a revenue share of 105.66% in 2024. Horizon Databook has segmented the Europe dog vaccine market based on modified/attenuated live covering the revenue growth of each sub-segment from 2018 to 2030.


The European Dogs Vaccines Market holds a second largest market share. The high companion population in the region is anticipated to contribute to steady growth over the predicted period. For example, the FEDIAF 2022 research estimates that 90 million homes in the EU have a pet (46%) and that there are around 90 million dogs. 

Additionally, action plans have been initiated by the European Medicines Agency (EMA) and its regulatory network partners to enhance and expand the accessibility of biologics and animal medications in Europe. 

To promote animal welfare and public health, several initiatives are being carried out. Over the years, the EMA has taken a number of steps to promote prompt access to animal vaccinations on the European market. 

Reasons to subscribe to Europe dog vaccine market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe dog vaccine market databook

  • Our clientele includes a mix of dog vaccine market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe dog vaccine market , including forecasts for subscribers. This continent databook contains high-level insights into Europe dog vaccine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online